EGLN2 Antibody (Center) Blocking Peptide

Artikelnummer: ABT-BP8703C
Artikelname: EGLN2 Antibody (Center) Blocking Peptide
Artikelnummer: ABT-BP8703C
Hersteller Artikelnummer: BP8703c
Alternativnummer: ABT-BP8703C-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: Egl nine homolog 2, Estrogen-induced tag 6, HPH-3, Hypoxia-inducible factor prolyl hydroxylase 1, HIF-PH1, HIF-prolyl hydroxylase 1, HPH-1, Prolyl hydroxylase domain-containing protein 1, PHD1, EGLN2, EIT6
EGLN2 catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates HIF-1 alpha at Pro-402 and Pro-564, and HIF-2 alpha. It functions as a cellular oxygen sensor and, under normoxic conditions, targets HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. It may play a role in cell growth regulation.
NCBI: 112398
UniProt: Q96KS0
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP8703c was selected from the Center region of human EGLN2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.